News from fujifilm diosynth biotechnologies A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Mar 18, 2021, 15:22 ET Fujifilm Selects North Carolina as the Location to Build the Largest Cell Culture Biopharmaceutical CDMO Facility in North America

FUJIFILM Corporation (President: Kenji Sukeno) has announced the selection of Holly Springs, North Carolina as the location for its new large-scale...

Mar 04, 2021, 10:23 ET FUJIFILM Diosynth Biotechnologies begynder større udvidelse af sit omfattende anlæg til biologisk produktion i Danmark

Mar 03, 2021, 11:57 ET FUJIFILM Diosynth Biotechnologies Breaks Ground For Major Expansion Of Its Large Scale Biologics Production Facility In Denmark

Mar 03, 2021, 11:51 ET FUJIFILM Diosynth Biotechnologies Breaks Ground For Major Expansion Of Its Large Scale Biologics Production Facility In Denmark

FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral ...

Jan 14, 2021, 07:09 ET Fujifilm and the Center for Advanced Biological Innovation and Manufacturing Announce $76M in Funding for Manufacturing and Innovation Center

FUJIFILM Corporation (COO: Kenji Sukeno) and the Center for Advanced Biological Innovation and Manufacturing (CABIM), today announced that it has...

Jan 06, 2021, 21:30 ET Fujifilm to Invest Over 200 Billion yen (2 Billion USD) to Establish New Large-Scale Cell Culture Manufacturing Site for Biopharmaceuticals in the U.S.A.

FUJIFILM Corporation (President: Kenji Sukeno) is making an investment of more than 200 Billion yen (2 Billion USD) to establish a new large-scale...

Jan 04, 2021, 21:00 ET Fujifilm to invest $40 Million to Establish a New State-of-the-Art Viral Vector and Advanced Therapy Process Development and Manufacturing Facility

FUJIFILM Corporation (President: Kenji Sukeno) will make a major capital investment of approximately 4 billion yen ($40 million) in FUJIFILM Diosynth ...

Aug 19, 2020, 14:21 ET FUJIFILM Diosynth Biotechnologies Breaks Ground For Advanced Therapies Innovation Center In Texas

FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene...

Jul 27, 2020, 16:11 ET FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing

FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene...

Jul 23, 2020, 16:04 ET Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate

Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and FUJIFILM...

Jun 09, 2020, 09:00 ET Fujifilm investerer 100 milliarder japanske yen (EUR 807 mio). i udvidelse af sit produktionssite til fremstilling af biologiske lægemidler i Hillerød, Danmark

Jun 09, 2020, 09:00 ET Fujifilm to invest 100 billion yen (807 million EUR) to expand its large scale biologics production facility in Denmark

Jun 09, 2020, 09:00 ET Fujifilm to invest 100 billion yen (928 million USD) to expand its large scale biologics production facility in Denmark

FUJIFILM Corporation (President: Kenji Sukeno) will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark ...

Apr 30, 2020, 09:00 ET FUJIFILM Diosynth Biotechnologies indgår partnerskab med COVID-19 Therapeutics Accelerator om adgang til produktionskapacitet og teknisk ekspertise til fremstilling af lægemidler mod COVID-19

Apr 30, 2020, 09:00 ET FUJIFILM Diosynth Biotechnologies teams with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies

FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), today announced that it will ...

Apr 30, 2020, 09:00 ET FUJIFILM Diosynth Biotechnologies teams with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies

Apr 23, 2020, 09:00 ET FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE™ To Address Supply Bottlenecks In Gene Therapy Development And Manufacturing

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in...

Mar 18, 2020, 08:00 ET Fujifilm Invests $83M USD to Expand FUJIFILM Diosynth Biotechnologies Microbial Capacity

FUJIFILM Corporation announced today that it will invest approximately 9 billion yen ($83M USD) to expand the microbial production capacity of...

Mar 16, 2020, 12:00 ET FUJIFILM Diosynth Biotechnologies Announces Appointment Of Christine Vannais As Chief Operating Officer For Its North Carolina Site

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in...

Mar 12, 2020, 09:32 ET FUJIFILM Diosynth Biotechnologies Breaks Ground On A New BioCampus At Its Billingham, UK Location

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in...

Mar 09, 2020, 13:00 ET FUJIFILM Diosynth Biotechnologies Announces Planned Leadership Succession

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in...

Feb 28, 2020, 09:00 ET FUJIFILM Diosynth Biotechnologies Expands Its Gene Therapy Manufacturing Capacity At Its College Station, Texas Location

FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its...

Feb 25, 2020, 14:24 ET FUJIFILM Diosynth Biotechnologies Expands Its North Carolina Facility Cell Culture And Microbial Capacity

FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDB), a Biologics Contract Development and Manufacturing Organization with experience focused on the...

Dec 03, 2019, 08:57 ET FUJIFILM Diosynth Biotechnologies Named A Top Ten Healthiest Employer Nationally

FUJIFILM Diosynth Biotechnologies (FDB), a leading global biologics Contract Development and Manufacturing Organization (CDMO), placed ninth in the...

Nov 25, 2019, 11:07 ET FUJIFILM Diosynth Biotechnologies Announces Its Participation As A Founding Member For The Establishment Of A New Center For Innovation And Manufacturing In Boston, Massachusetts

FUJIFILM Diosynth Biotechnologies (FDB), a leading global biologics and gene therapy Contract Development and Manufacturing Organization (CDMO) has...